| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $553.2M | -0.3% |
| Cost of Revenue | $153.2M | +0.8% |
| R&D Expense | $68.0M | -2.5% |
| SG&A Expense | $95.9M | -12.5% |
| Operating Income | -$308.6M | +61.6% |
| Interest Expense | $65.3M | +22.1% |
| Pre-tax Income | -$364.9M | +56.1% |
| Income Tax | -$16.3M | +60.3% |
| Net Income | -$349.3M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $136.3M | -20.0% |
| Accounts Receivable | $185.6M | +1.1% |
| Current Assets | $385.3M | -5.0% |
| Total Assets | $1.27B | -22.5% |
| Current Liabilities | $413.2M | -2.8% |
| Long-term Debt | $577.5M | -0.7% |
| Stockholders' Equity | $205.6M | -61.3% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.8M | +113.5% |
| Capital Expenditures | $4.2M | -14.9% |
| Investing Cash Flow | -$23.0M | +45.4% |
| Financing Cash Flow | -$10.8M | -114.0% |
| Free Cash Flow | -$1.4M | +94.7% |
| +51.8% |
| EPS (Basic) | -$43.38 | -851.3% |